Real-time enrollment status for this idiopathic parkinson´s disease clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 10:19 PM UTC
| NCT Number | NCT07106021 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Parkinson´s Disease |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Kenai Therapeutics |
| Last Updated on CT.gov | January 23, 2026 (Jan 23, 2026) |
As of July 16, 2026: Clinical trial NCT07106021 is currently recruiting participants. This phase1 study for idiopathic parkinson´s disease is actively seeking new participants at 3 locations across the United States. The study is sponsored by Kenai Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07106021 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07106021 was last updated Jan 23, 2026 (January 23, 2026). HelloStudys verifies this status automatically.